Become A Featured Company

Alternative Consumption Methods That Are Reshaping the Cannabis Industry

Ryan Allway

July 30th, 2019

App, Exclusive, News, Top News

 

The cannabis industry is projected to reach $66.3 billion by 2025, according to Grand View Research, representing a 23.9% compound annual growth rate. While cannabis flower began as the largest subset of the market, concentrates and edibles have quickly gained market share over the past several years. The medical cannabis industry has also seen a lot of interesting research and development designed to improve treatment options.

In this article, we will take a look at key trends in both recreational and medical cannabis consumption methods, and how companies like Cannova Medical Ltd. (49% owned by Nabis Holdings Inc. (CSE: NAB) (OTC: INNPF) (FRA: 71P)) are positioning themselves in the market.

Click here to receive an investor deck and corporate updates

Concentrates Outpace Flower Sales

Cannabis concentrate sales are projected to reach $8 billion by 2022, according to BDS Analytics and Arcview Market Research, making them the fastest growing segment of the local cannabis market. With vape pens becoming increasingly popular, the analysts believe that the vaporizers will represent about $6.5 billion of the $8 billion in concentrate sales — making vaporizers the fastest growing subset of the space.

 

While cultivators benefit from lower production costs — since there’s no need to trim or cure product, concentrates take up less space for distributors to house and transport and they have higher profit margins that make them attractive to retailers. There may also be long-term environmental benefits to concentrate production since outdoor production is more viable and there’s less waste with longer shelf lives than cannabis flower.

Beverages represent another key subset of the concentrates market poised for rapid growth in the recreational side of the market. Many alcohol companies have already made investments in the space in anticipation of THC-infused beverages becoming popular among consumers, while traditional beverage giants have started to explore investments in the space with regards to non-psychoactive CBD-infused beverages.

Click here to receive an investor deck and corporate updates

Innovations in Medical Cannabis Delivery

Cannabis flower, concentrates and edibles may be the three categories that most analysts and investors focus on, but innovative new products are transcending these labels — particularly in the medical cannabis space. Medical cannabis users often require precise dosages that are difficult to obtain reliably at dispensaries, while they may not be comfortable with smoking or vaping as a delivery mechanism for medical reasons.

Cannova Medical Ltd., which is 49% owned by Nabis Holdings Inc. (CSE: NAB) (OTC: INNPF) (FRA: 71P), has developed a patented sublingual strip technology designed to be more convenient for consumers than smoking, vaping or consuming oil. With its patented countertop device, consumers can access precise and personalized doses of THC, CBD and other active ingredients to meet their unique, requirements in real-time.

“The possibilities are incredibly exciting. From a medicinal perspective, alternative means of consumption widen the consumer demographic to reap the benefits of medical cannabis. On the retail side, the profit margins are higher on new technology products as opposed to edibles and flower, making them attractive to dispensary owners.”, says Nabis Holdings CEO Shay Shnet.

Click here to receive an investor deck and corporate updates

The cutting-edge platform designed for home use looks similar to a countertop espresso or coffee machine. After inputting their specific requirements, users can easily create sublingual strips that are designed to mask the unpleasant taste of cannabinoids, increase their bioavailability, and reduce their onset time by bypassing liver metabolism. The goal is to provide a consistent experience that’s personalized for each individual.

Trends to Watch in the Future

Cannabis consumption methods have evolved from smoking cannabis flower to vaping, edibles, beverages and other categories. Within the medical cannabis market, there has been even greater focus on innovative R&D projects designed to improve convenience, dosing and bioavailability. Many physicians are hesitant to prescribe medical cannabis due to the lack of consistent dosing and measurability compared to pharmaceuticals.

Those interested in investing in these trends may want to consider companies like Nabis Holdings Inc. (CSE: NAB) (OTC: INNPF) (FRA: 71P) given its investment in the space. In addition to its investment in Cannova Medical, the company is building a portfolio of cultivation and retail facilities in states like Arizona, California and Michigan with a focus on companies capable of adding near-term EBITDA with shareholder-aligned incentives.

For more information, visit the company’s website at www.nabisholdings.com.

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

The above article is sponsored content.

Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading